According to Axsome Therapeutics 's latest financial reports the company's current earnings (TTM) are -$0.24 B. In 2022 the company made an earning of -$0.19 B a decrease over its 2021 earnings that were of -$0.14 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.24 B | 27.33% |
2022 | -$0.19 B | 43.5% |
2021 | -$0.14 B | 26.73% |
2020 | -$0.11 B | 50.56% |
2019 | -$68.35 M | 120.71% |
2018 | -$30.97 M | 6.99% |
2017 | -$28.95 M | 6.4% |
2016 | -$27.21 M | 157.6% |
2015 | -$10.56 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | -53.51% | ๐บ๐ธ USA |